Translational Pharmacology Core
"Integrating Translational and Clinical Pharmacology Research within the Center of Excellence in Bioinformatics and Life Sciences"
Translational Pharmacology Group Director:
Gene D. Morse, Pharm.D., FCCP, BCPS
Professor, Pharmacy Practice, Medicine and Pediatrics
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Overview
The New York State Center of Excellence in Bioinformatics and Life Sciences (COE) has established a Translational Pharmacology Core (TPC) within the developing research infrastructure. The goals of the TPC core will be:
- To foster innovative translational pharmacology research in the areas of drug development, applied translational pharmacology, clinical pharmacology and pharmacogenomics and proteomics with an emphasis in oncology, neurology, infectious diseases and inflammation and cardiovascular disease.
- To facilitate collaboration among COE investigators with common areas of research interest and foster an interdisciplinary, interactive environment that stimulates grant submission and commercialization of drugs, drug delivery systems and diagnostics.
- To establish an integrated program that utilizes novel strategies for transitioning from pre-clinical drug development to a clinical research environment to optimize the approval process and provide a forum for exchange for research ideas through an interdisciplinary seminar program with presentations by national and international visiting scholars.
Description of the Translational Pharmacology Core (TPC)
1. The TPC provides a novel research program that will interface with multiple stages of drug development including drug discovery, pre-clinical evaluation, Phase I, II and III of the required FDA approval process as well as a developing network for conducting Phase IV (post-approval) research.
2. The TPC will foster the interaction of basic and clinical scientists who are focused on drug development and translational pharmacology.
3. The TPC will utilize in vitro experimental therapeutics models that will facilitate integrated pre-clinical approaches to pharmacokinetic, pharmacodynamic and pharmacogenetic investigations accompanied by in silico modeling techniques.
4. The TPC will facilitate novel approaches to examine clinical challenges within a interdisciplinary laboratory environment.
5. The COE TPC facilities will provide an efficient system with a quality assurance program to sustain standard operating procedures that are recognized as industry standards and an essential component for the pharmaceutical industry to recognize the COE as a primary site for drug development research.
6. Data management and data analysis units within the COE will be linked with clinical facilities through the UB Clinical and Translational Research Center, the Center for Computational Research (CCR) and National Center for Ontological Research.
The development of the TPC within the COE research infrastructure will accelerate the ability of the COE to develop pre-clinical, translational and clinical research programs for new therapeutics and devices. In addition corporate partners will be seeking to join the COE collaboration and this will foster the goal of commercialization and regional economic development.
Visit the website to learn more at www.isciwny.com
Follow cool careers: 
Connect with entrepreneurs, investors, and community leaders: 
UB CENTER FOR ADVANCED BIOMEDICAL AND BIOENGINEERING TECHOLOGY
(UB CAT)
UB CAT is now accepting 2012-2013 technology development project applications. Click here to learn more.
Events
To view the complete list of events and event details, please visit our Events page.
2012 Venture Forum - May 16-17; Buffalo, NY. To learn more, visit www.brightbuffaloniagara.com
2012 Pre-Seed
Workshop - June 4, 5 & 12, Center of Excellence. For more info email Renata Bator at rmbator@buffalo.edu
To receive periodic News & Events emails from the COE, please join our mailing list!
News
Investors Come Looking for Deals in Upstate/Western New York
5/14/2012 - BUFFALO, NY – “Downstate and out-of-town investors are coming to Buffalo in May looking for deals and new ideas. The 2012 Venture Forum is attracting new attention from investment firms from New York City, Ohio, California, Maryland, Illinois and Pennsylvania...” [Read On…]
Conference to Match Startups, Investors: Venture Forum 2012 Merges Two Initiatives
5/12/2012 - BUFFALO, NY – “The Buffalo Niagara region is hosting a joint conference next week aimed at encouraging innovation in the private sector and introducing entrepreneurs to the investors who can help bring their bright ideas to the marketplace...” [Buffalo News Article]
Visit the News Archive
